These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 2770288)

  • 21. Influence of the monocyte culture on thromboxane A2 level and platelet aggregation.
    Giedrojć J; Czaczkowska T; Bielawiec M
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1990; 117(3):479-84. PubMed ID: 1703121
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Local amplification of platelet function by 8-Epi prostaglandin F2alpha is not mediated by thromboxane receptor isoforms.
    Praticò D; Smyth EM; Violi F; FitzGerald GA
    J Biol Chem; 1996 Jun; 271(25):14916-24. PubMed ID: 8663015
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Arachidonic acid metabolism in platelets].
    Harada Y; Katori M
    Rinsho Byori; 1985 Jul; 33(7):722-5. PubMed ID: 4068260
    [No Abstract]   [Full Text] [Related]  

  • 24. Role of phosphoinositide 3-kinase beta in platelet aggregation and thromboxane A2 generation mediated by Gi signalling pathways.
    Garcia A; Kim S; Bhavaraju K; Schoenwaelder SM; Kunapuli SP
    Biochem J; 2010 Jul; 429(2):369-77. PubMed ID: 20441566
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effects of dietary supplementation with cod-liver oil on endothelium-dependent responses in porcine coronary arteries.
    Shimokawa H; Lam JY; Chesebro JH; Bowie EJ; Vanhoutte PM
    Circulation; 1987 Oct; 76(4):898-905. PubMed ID: 3115623
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Zinc-induced platelet aggregation is mediated by the fibrinogen receptor and is not accompanied by release or by thromboxane synthesis.
    Heyns Adu P; Eldor A; Yarom R; Marx G
    Blood; 1985 Jul; 66(1):213-9. PubMed ID: 2988668
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effects of sodium selenite on in vitro interactions between platelets and endothelial cells.
    Ricetti MM; Guidi GC; Tecchio C; Bellisola G; Rigo A; Perona G
    Int J Clin Lab Res; 1999; 29(2):80-4. PubMed ID: 10436266
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Inhibition of platelet 5-HT secretion and of 5-HT induced vasoconstriction by paracetamol.
    Verheggen R; Schrör K
    Prog Clin Biol Res; 1987; 242():271-6. PubMed ID: 3671387
    [No Abstract]   [Full Text] [Related]  

  • 29. TXA2-antagonistic properties of agents affecting prostaglandin synthesis or the cyclic nucleotide system in human platelets.
    Kangasaho M; Vapaatalo H
    Acta Pharmacol Toxicol (Copenh); 1983 Aug; 53(2):130-4. PubMed ID: 6624480
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Inhibition of thromboxane A2 synthesis in human platelets by coagulation factor Xa.
    Sinha AK; Rao AK; Willis J; Colman RW
    Proc Natl Acad Sci U S A; 1983 Oct; 80(19):6086-90. PubMed ID: 6577468
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Platelet hypersensitivity in cholesterol-fed rabbits: enhancement of thromboxane A2-dependent and thrombin-induced, thromboxane A2-independent platelet responses.
    Gross PL; Rand ML; Barrow DV; Packham MA
    Atherosclerosis; 1991 May; 88(1):77-86. PubMed ID: 1878012
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Generation of thromboxane A2 and aorta-contracting activity from platelets stimulated with modified C-reactive protein.
    Simpson RM; Prancan A; Izzi JM; Fiedel BA
    Immunology; 1982 Sep; 47(1):193-202. PubMed ID: 7118160
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Influence of propranolol and 4-hydroxypropranolol on platelet aggregation and thromboxane A2 generation.
    Mehta J; Mehta P; Ostrowski N
    Clin Pharmacol Ther; 1983 Nov; 34(5):559-64. PubMed ID: 6627818
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prostaglandin H2 in human platelet activation: coactivator and substitute for thromboxane A2.
    Hornberger WB; Patscheke H
    Prog Clin Biol Res; 1989; 301():315-9. PubMed ID: 2798452
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Can we use adenosine diphosphate (ADP) to study "aspirin resistance"? The Janus faces of ADP-triggered platelet aggregation.
    Dobaczewski M; Golański J; Kowalski T; Nocuń M; Rózalski M; Kostka B; Ulicna O; Mussur M; Markuszewski L; Watała C
    Pharmacol Rep; 2008; 60(3):361-8. PubMed ID: 18622061
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Platelet function and biosynthesis of prostacyclin and thromboxane A2 in whole blood after aspirin administration in human subjects.
    Mehta JL; Mehta P; Lopez L; Ostrowski N; Aguila E
    J Am Coll Cardiol; 1984 Oct; 4(4):806-11. PubMed ID: 6384329
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Losartan inhibits thromboxane A2-induced platelet aggregation and vascular constriction in spontaneously hypertensive rats.
    Li P; Ferrario CM; Brosnihan KB
    J Cardiovasc Pharmacol; 1998 Aug; 32(2):198-205. PubMed ID: 9700980
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Platelet function in Watanabe heritable hyperlipidemic rabbits. Decreased sensitivity to thromboxane A2.
    Gross PL; Rand ML; Barrow DV; Packham MA
    Arterioscler Thromb; 1991; 11(3):610-6. PubMed ID: 2029501
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Biological actions of prostacyclin and its pharmacological use in platelet studies.
    Moncada S; Whittle BJ
    Adv Exp Med Biol; 1985; 192():337-58. PubMed ID: 3010671
    [No Abstract]   [Full Text] [Related]  

  • 40. Why do some beta adrenergic agonists inhibit generation of thromboxane A2 in incubates of platelets with arachidonic acid?
    Chignard M; Vargaftig BB
    Biochem Pharmacol; 1978; 27(11):1603-6. PubMed ID: 29642
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.